Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants.

Bertilsson L, Aberg-Wistedt A, Gustafsson LL, Nordin C.

Ther Drug Monit. 1985;7(4):478-80. No abstract available.

PMID:
4082245
3.

Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients.

Solai LK, Pollock BG, Mulsant BH, Frye RF, Miller MD, Sweet RA, Kirshner M, Sorisio D, Begley A, Reynolds CF 3rd.

J Clin Psychopharmacol. 2002 Oct;22(5):481-6.

PMID:
12352271
4.

Slow hydroxylation of tricyclic antidepressants--relationship to polymorphic drug oxidation.

Sjöqvist F, Bertilsson L.

Prog Clin Biol Res. 1986;214:169-88. Review.

PMID:
3523507
5.

Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man.

Bertilsson L, Eichelbaum M, Mellström B, Säwe J, Schulz HU, Sjöqvist F.

Life Sci. 1980 Nov 3;27(18):1673-7. No abstract available.

PMID:
7442467
6.

Amitriptyline pharmacokinetics and clinical response: II. Metabolic polymorphism assessed by hydroxylation of debrisoquine and mephenytoin.

Baumann P, Jonzier-Perey M, Koeb L, Küpfer A, Tinguely D, Schöpf J.

Int Clin Psychopharmacol. 1986 Apr;1(2):102-12.

PMID:
3571939
7.

E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.

Mellström B, Bertilsson L, Säwe J, Schulz HU, Sjöqvist F.

Clin Pharmacol Ther. 1981 Aug;30(2):189-93.

PMID:
7249504
8.

Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects.

Woolhouse NM, Adjepon-Yamoah KK, Mellström B, Hedman A, Bertilsson L, Sjöqvist F.

Clin Pharmacol Ther. 1984 Sep;36(3):374-8.

PMID:
6467797
9.

The effectiveness of tricyclic antidepressants on lumbar spinal stenosis.

Orbai AM, Meyerhoff JO.

Bull NYU Hosp Jt Dis. 2010;68(1):22-4.

10.

Correlation between nortriptyline and debrisoquine hydroxylation in the human liver.

von Bahr C, Birgersson C, Blanck A, Göransson M, Mellström B, Nilsell K.

Life Sci. 1983 Aug 15;33(7):631-6.

PMID:
6410141
11.

Tricyclic-resistant depression: treatment resistance or inadequate treatment?

Lydiard RB.

J Clin Psychiatry. 1985 Oct;46(10):412-7. Review.

PMID:
3900051
12.

[Pharmacogenetics of antidepressant metabolism. Value of the debrisoquin test].

Baumann P.

Encephale. 1986 Jul-Aug;12(4):143-8. French.

PMID:
3792273
13.

Dosing of antidepressants--the unknown art.

Jerling M.

J Clin Psychopharmacol. 1995 Dec;15(6):435-9.

PMID:
8748433
14.

Initiation of tricyclic treatment at full dose.

Nelson JC.

J Clin Psychiatry. 1994 Jun;55(6):266-7. No abstract available.

PMID:
8071287
15.

Interactions of cyclobenzaprine and tricyclic antidepressants.

Rosenlicht NZ, Riley-Lazo KP.

J Clin Psychiatry. 2005 Jan;66(1):134-5. No abstract available.

PMID:
15669899
16.

Rapid conjugation in an extremely rapid hydroxylator of debrisoquine: a case report supporting a coregulation of certain phase I and II metabolic reactions.

Bertilsson L, Aberg-Wistedt A, Dumont E, Lundström J.

Ther Drug Monit. 1988;10(2):242-4. No abstract available.

PMID:
2968008
17.

Treating delusional depressives with amitriptyline.

Spiker DG, Dealy RS, Hanin I, Weiss JC, Kupfer DJ.

J Clin Psychiatry. 1986 May;47(5):243-6.

PMID:
3516978
18.

Nortriptyline pharmacokinetics and plasma levels: implications for clinical practice.

Rubin EH, Biggs JT, Preskorn SH.

J Clin Psychiatry. 1985 Oct;46(10):418-24. Review.

PMID:
3900052
19.

Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: clinical implications.

Bertilsson L, Mellström B, Sjökvist F, Mårtenson B, Asberg M.

Lancet. 1981 Mar 7;1(8219):560-1. No abstract available.

PMID:
6111662
20.

Polymorphic hydroxylation of debrisoquine.

Tucker GT, Silas JH, Iyun AO, Lennard MS, Smith AJ.

Lancet. 1977 Oct 1;2(8040):718. No abstract available.

PMID:
71525

Supplemental Content

Support Center